| 05/12 | TODAY'S ANALYST RECOMMENDATIONS : Aston Martin, Cisco, HSBC, Tyson Foods, Merck... | |
| 05/11 | ASTRAZENECA : Goldman Sachs maintains a Sell rating | MD |
| 05/11 | ASTRAZENECA : Buy rating from Deutsche Bank | MD |
| 05/07 | ASTRAZENECA : UBS reaffirms its Buy rating | MD |
| 05/06 | ASTRAZENECA : Liberum Boosts AstraZeneca PT, Maintains Buy Rating | MT |
| 05/04 | ASTRAZENECA : Credit Suisse remains its Buy rating | MD |
| 05/04 | ASTRAZENECA : Deutsche Bank reaffirms its Buy rating | MD |
| 05/03 | ASTRAZENECA : Gets a Buy rating from Kepler Cheuvreux | MD |
| 05/03 | TODAY’S ANALYST RECOMMENDATIONS : AstraZeneca, Barclays, Commerzbank… | |
| 05/03 | ASTRAZENECA : DZ Bank keeps a Sell rating | MD |
| 05/03 | ASTRAZENECA : Credit Suisse reiterates its Buy rating | MD |
| 04/30 | ASTRAZENECA : UBS maintains a Buy rating | MD |
| 04/30 | ASTRAZENECA : Jefferies keeps its Buy rating | MD |
| 04/30 | ASTRAZENECA : Sell rating from Goldman Sachs | MD |
| 04/19 | ASTRAZENECA : UBS maintains a Buy rating | MD |
| 04/14 | ASTRAZENECA : UBS maintains a Buy rating | MD |
| 04/12 | ASTRAZENECA : Argus Research Downgrades AstraZeneca to Hold From Buy | MT |
| 04/07 | ASTRAZENECA : Credit Suisse remains its Buy rating | MD |
| 04/07 | ASTRAZENECA : UBS gives a Buy rating | MD |
| 03/26 | NOVAVAX : B. Riley Lowers Novavax' PT to $365 from $397, Says AstraZeneca's AZD.. | MT |
| 03/26 | ASTRAZENECA : UBS maintains a Buy rating | MD |
| 03/23 | ASTRAZENECA : SocGen Reaffirms AstraZeneca at Buy, Boosts PT | MT |
| 03/23 | ASTRAZENECA : UBS maintains a Buy rating | MD |
| 03/22 | ASTRAZENECA : Buy rating from Barclays | MD |
| 03/22 | ASTRAZENECA : Goldman Sachs maintains a Sell rating | MD |
| 03/18 | ASTRAZENECA : Deutsche Bank Raises AstraZeneca PT, Maintains Buy Rating | MT |
| 03/18 | ASTRAZENECA : Deutsche Bank keeps its Buy rating | MD |
| 03/17 | ASTRAZENECA : Sell rating from Goldman Sachs | MD |
| 03/16 | ASTRAZENECA : Jefferies Upgrades AstraZeneca to Buy from Hold, Boosts PT | MT |
| 03/16 | ASTRAZENECA : Jefferies Upgrades AstraZeneca to Buy From Hold | MT |
| 03/16 | ASTRAZENECA : Jefferies raises its recommendation to Buy | MD |
| 03/09 | ASTRAZENECA : Berenberg Cuts AstraZeneca PT, Maintains Buy Rating | MT |
| 03/08 | ASTRAZENECA : Berenberg reiterates its Buy rating | MD |
| 03/08 | ASTRAZENECA : Barclays Lifts AstraZeneca PT, Keeps Overweight Rating | MT |
| 03/08 | ASTRAZENECA : Barclays gives a Buy rating | MD |
| 03/02 | ASTRAZENECA : Goldman Sachs Ups AstraZeneca PT, Maintains Sell Rating | MT |
| 03/02 | ASTRAZENECA : Buy rating from UBS | MD |
| 03/01 | ASTRAZENECA : Goldman Sachs remains a Sell rating | MD |
| 02/25 | ASTRAZENECA : UBS Upgrades AstraZeneca to Buy From Neutral on 'Cleaner Profile'.. | MT |
| 02/25 | ASTRAZENECA : Upgraded to Buy by UBS | MD |
| 02/25 | ASTRAZENECA : UBS Upgrades AstraZeneca to Buy From Neutral, Boosts PT | MT |
| 02/18 | ASTRAZENECA : UBS sticks Neutral | MD |
| 02/17 | ASTRAZENECA : Goldman Sachs remains a Sell rating | MD |
| 02/16 | ASTRAZENECA : Gets a Buy rating from Deutsche Bank | MD |
| 02/15 | ASTRAZENECA : Liberum Lowers AstraZeneca PT, Keeps Buy Rating | MT |
| 02/15 | ASTRAZENECA : Deutsche Bank gives a Buy rating | MD |
| 02/12 | ASTRAZENECA : Deutsche Bank reiterates its Buy rating | MD |
| 02/12 | ASTRAZENECA : Buy rating from Credit Suisse | MD |
| 02/11 | ASTRAZENECA : Barclays gives a Buy rating | MD |
| 02/11 | ASTRAZENECA : Gets a Neutral rating from UBS | MD |
| 02/11 | ASTRAZENECA : Goldman Sachs keeps a Sell rating | MD |
| 02/11 | ASTRAZENECA : Gets a Neutral rating from Jefferies | MD |
| 02/10 | ASTRAZENECA : Buy rating from Deutsche Bank | MD |
| 02/08 | ASTRAZENECA : UBS reaffirms its Neutral rating | MD |
| 02/03 | ASTRAZENECA : Buy rating from Deutsche Bank | MD |
| 02/01 | ASTRAZENECA : Deutsche Bank reiterates its Buy rating | MD |
| 01/26 | ASTRAZENECA : UBS reiterates its Neutral rating | MD |
| 01/25 | ASTRAZENECA : Goldman Sachs maintains a Sell rating | MD |
| 01/22 | ASTRAZENECA : Goldman Sachs maintains a Sell rating | MD |
| 01/22 | ASTRAZENECA : Barclays reaffirms its Buy rating | MD |
| 01/20 | ASTRAZENECA : Receives a Buy rating from Credit Suisse | MD |
| 01/20 | ASTRAZENECA : Jefferies sticks Neutral | MD |
| 01/15 | ASTRAZENECA : Deutsche Bank Initiates Coverage on AstraZeneca With Buy Rating | MT |
| 01/15 | ASTRAZENECA : Buy rating from Deutsche Bank | MD |
| 01/15 | ASTRAZENECA : Buy rating from Berenberg | MD |
| 01/14 | ASTRAZENECA : UBS reaffirms its Neutral rating | MD |
| 01/11 | ASTRAZENECA : SocGen Trims AstraZeneca PT, Maintains Buy Rating | MT |
| 2020 | ASTRAZENECA : AlphaValue Upgrades AstraZeneca to Add from Reduce | MT |
| 2020 | ASTRAZENECA : Receives a Sell rating from Goldman Sachs | MD |
| 2020 | ASTRAZENECA : Liberum Trims AstraZeneca PT, Maintains Buy Rating | MT |
| 2020 | ASTRAZENECA : Gets a Sell rating from DZ Bank | MD |
| 2020 | ALEXION PHARMACEUTICALS : Credit Suisse Downgrades Alexion to Neutral from Outp.. | MT |
| 2020 | ASTRAZENECA : Receives a Buy rating from Kepler Cheuvreux | MD |
| 2020 | ASTRAZENECA : UBS gives a Neutral rating | MD |
| 2020 | ASTRAZENECA : Credit Suisse reiterates its Buy rating | MD |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
